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Abstract 
Despite widespread recognition that attention-deficit/hyperactivity disorder (ADHD) is a lifelong 
neurodevelopmental disorder, optimal methods of diagnosis among adults remain elusive. Substantial overlap 
between ADHD symptoms and cognitive symptoms of other mental health conditions, such as depression and 
anxiety, and concerns about validity in symptom reporting have made the use of neuropsychological tests in 
ADHD diagnostic assessment appealing. However, past work exploring the potential diagnostic utility of 
neuropsychological tests among adults has often relied on a relatively small subset of tests, has failed to include 
symptom and performance validity measures, and often does not include comparison groups of participants 
with commonly comorbid disorders, such as depression. The current study examined the utility of an extensive 
neuropsychological measure battery for diagnosing ADHD among adults. Two hundred forty-six participants (109 
ADHD, 52 depressed, 85 nondisordered controls) completed a multistage screening and assessment process, 
which included a clinical interview, self, and informant report on behavior rating scales, performance and 
symptom validity measures, and an extensive neuropsychological testing battery. Results indicated that 
measures of working memory, sustained attention, response speed, and variability best discriminated ADHD and 
non-ADHD participants. While single test measures provided performed poorly in identifying ADHD participants, 
analyses revealed that a combined approach using self and informant symptom ratings, positive family history of 
ADHD, and a reaction time (RT) variability measure correctly classified 87% of cases. Findings suggest that 
neuropsychological test measures used in conjunction with other clinical assessments may enhance prediction 
of adult ADHD diagnoses. 
Public Significance Statement 
Public Significance Statement: This study suggests that cognitive tests may be most useful in the diagnostic 
assessment of ADHD among adults when used in combination with symptom report scales and family history 
information. These results caution against the use of cognitive tests alone in the diagnostic process and 
emphasize inclusion of performance validity measures and measures of depression when evaluating ADHD 
among adults. 
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Introduction 
Once considered a disorder of childhood, it is now widely recognized that attention-deficit/hyperactivity 
disorder (ADHD) is a lifelong neurodevelopmental syndrome (Kessler et al., 2005). Recent national surveys have 
estimated prevalence of ADHD as high as 11% among youth (Visser et al., 2014), however, prevalence estimates 
are somewhat lower among adults, ranging between 2% to 6%, depending on the criteria used (Barkley, 
Murphy, & Fischer, 2008; Vitola et al., 2017). These prevalence estimates have increased over the past decade, 
leading to growing concerns that ADHD may be overdiagnosed, particularly among adults (Hinshaw & Sheffler, 
2014; Paris, Bhat, & Thombs, 2015). Supporting this concern, prescriptions for ADHD medications for patients 
between the ages of 20 and 39 have substantially increased in the past 10 years (Johansen, Matic, & 
McAlearney, 2015; Renoux, Shin, Dell’Aniello, Fergusson, & Suissa, 2016), with estimates suggesting anywhere 
between a 280 and 800% increase in stimulant medication prescriptions for adults since the early 2000s. 
 
Determining the optimal diagnostic assessment procedures for ADHD among adults remains a critical 
component to the continued study of its phenomenology, correlates, developmental course, and treatment. 
However, multiple challenges remain in the assessment of adult ADHD, both for research and clinical purposes. 
First, many young adults, especially college students, experience occasional ADHD symptoms, particularly 
inattention-disorganization (Drake, Riccio, & Hale, 2017; DuPaul, Weyandt, O’Dell, & Varejao, 2009). Thus, it may 
be difficult for general medical professionals without specialized training in ADHD to differentiate between 
those with sufficient symptoms and impairment to warrant a diagnosis from those with occasional or situational 
difficulties (Epstein et al., 2014). This problem is also compounded by the fact that attention and concentration 
difficulties are nearly identical in description to cognitive symptoms of depression and anxiety and are often 
associated with similar cognitive deficits (Prevatt, Dehili, Taylor, & Marshall, 2015; Spencer, Biederman, & Mick, 
2007). Second, there may be secondary gains associated with endorsement of ADHD symptoms (particularly in 
college settings) including access to academic/work-related accommodations as well as stimulant medications 
(Advokat, Lane, & Luo, 2011; Arria et al., 2008). Inclusion of performance validity tests (PVTs) and symptom 
validity tests (SVTs) have been successful in identifying invalid symptom presentation among adults presenting 
for an evaluation of ADHD (Marshall, Hoelzle, Heyerdahl, & Nelson, 2016; Musso & Gouvier, 2014). However, it 
remains unclear how often issues of invalid symptom presentation are considered when evaluating the disorder 
in adults. Recent expert recommendations regarding the optimal means of assessing adult ADHD have pointed 
out the importance of including such validity measures (Ramsey, 2015). 
 
Third, only the most recent revision to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-
5; American Psychiatric Association, 2013) has specified adult-specific symptom wording and thresholds within 
the ADHD diagnostic criteria. Thus, application of adult-specific criteria may be unfamiliar to those making the 
diagnosis. The need for adult-specific symptom criteria and diagnostic thresholds caused significant debate 
during the DSM revision process (Bell, 2011) and continues to be contested in the literature (Matte et al., 2015; 
Sibley, Coxe, & Molina, 2017; Vitola et al., 2017). The current criteria rely on reports of current symptoms as well 
as retrospective reports of childhood behavior prior to Age 12. The accuracy of retrospective self-reports of 
childhood behavior remains somewhat questionable (Mannuzza, Klein, Klein, Bessler, & Shrout, 2002). However, 
prior work has demonstrated that specifying presence of symptoms before Age 12 (compared with Age 7 in 
DSM–IV) likely improved reliability of retrospective reports of symptoms while not substantially increasing the 
prevalence of adult ADHD (Kieling et al., 2010). Notably, the accuracy of diagnostic assessment of ADHD may be 
improved by including reports of symptoms from informants, such as parents (Dvorsky, Langberg, Molitor, & 
Bourchtein, 2016; Sibley et al., 2017) as well as considering family history of ADHD (Kooij et al., 2010), given 
work indicating significant heritability of ADHD (Nikolas & Burt, 2010). However, few studies have explicitly 
examined the extent to which inclusion of such information enhances diagnostic prediction. 
 
In general, an unstructured clinical interview combined with self-reports on behavioral rating scales of ADHD 
symptoms remain the most common tools used in diagnosing ADHD among adults (Dvorsky et al., 2016; Nelson, 
Whipple, Lindstrom, & Foels, 2014). Using neuropsychological testing has been proposed as one strategy to 
improve the accuracy of diagnostic assessment, given the range of cognitive deficits associated with ADHD in 
adulthood (Mostert et al., 2015; Weyandt, Oster, Gudmundsdottir, DuPaul, & Anastopoulos, 2017) as well as the 
continuation of neurocognitive problems into adulthood among those with ADHD (van Lieshout, Luman, 
Buitelaar, Rommelse, & Oosterlaan, 2013). Some past work has shown that inclusion of tests of executive 
functioning, particularly working memory and inhibition, as well as tests of sustained attention have improved 
diagnostic accuracy of ADHD assessment (Grodzinsky & Barkley, 1999; Lovejoy et al., 1999). More recently, 
machine learning paradigms have also been able to utilize neuropsychological data to accurately predict ADHD 
diagnoses among children (Bledsoe et al., 2016). However, other studies have also shown limited utility of these 
neuropsychological tests in improving diagnostic accuracy (Barkley et al., 2008; Rapport, Van Voorhis, Tzelepis, 
& Friedman, 2001). Notably, single neuropsychological tests have been found to poorly discriminate between 
youth with and without ADHD (Doyle, Biederman, Seidman, Weber, & Faraone, 2000) and normal performance 
on any given test has been shown to poorly predict the absence of ADHD (Perugini, Harvey, Lovejoy, Sandstrom, 
& Webb, 2000). This is likely due to the substantial heterogeneity in neuropsychological performance among 
those with and without ADHD (Fair, Bathula, Nikolas, & Nigg, 2012). 
 
While there is some indication that combined approaches (i.e., interview, behavior rating scale, and 
neuropsychological testing) may provide improved diagnostic accuracy (Perugini et al., 2000), past work 
exploring these questions has been limited in several ways. First, many studies have focused on a few 
neuropsychological domains and have not incorporated other tests commonly used in clinical 
neuropsychological practice, which may potentially be more sensitive in identifying ADHD-related cognitive 
deficits. Second, nearly all this work has failed to incorporate PVTs to ensure valid effort. Third, only one study of 
the diagnostic accuracy of a combined approach (including PVTs) has been done with adults, a group for which 
diagnosis remains particularly challenging. Many of these studies have failed to consider how measures might 
distinguish ADHD from those with other disorders, such as depression, that present with similar concentration 
and attention problems. Distinguishing between adult ADHD and depression is of particular importance, given 
the high rates of comorbidity between ADHD and depression in adults (Kessler et al., 2006) as well the common 
patterns of cognitive deficits associated with each condition (Prevatt et al., 2015; Spencer et al., 2007). Few prior 
studies have evaluated the degree to which each source of information (i.e., rating scales, test scores) improves 
diagnostic accuracy as well as how various cut scores available across many commonly used measures may 
impact their diagnostic utility. 
 
Therefore, the purpose of the current study was to examine performance across a large and diverse 
neuropsychological measure battery among adults with ADHD, adults with unipolar depression, and controls 
with the goal of determining if inclusion of such measures improved diagnostic accuracy of ADHD. Here, we also 
examined behavior rating scales from participants and informants that assessed current and childhood 
symptoms as well as current ADHD-related functional impairments, along with neuropsychological test 
performance to determine which combination of these measures resulted in the highest diagnostic accuracy of 
ADHD among adults. Based on prior work, we predicted that inclusion of tests of neuropsychological 
functioning, particularly sustained attention, would improve diagnostic accuracy for adult ADHD. 
Method 
Participants 
Participants were 256 adults Ages 18–40 years (Mage = 23.9 years, SD = 5.1 years, 60.6% female, 83.7% 
Caucasian). Adult volunteers were recruited via advertisements, e-mail listservs, and outreach to local 
neuropsychological clinics to obtain as representative a sample as possible while avoiding the inherent biases 
associated with relying on a purely clinic-referred sample. Study participants were recruited across two sites into 
one of three potential groups: adults with a diagnosis of ADHD, adults with a diagnosis of unipolar mood 
disorder (depressed), and adults with neither diagnosis (controls, see the Testing Procedures section). 
Enrollment in the study also required all participants to give contact information for an informant, who could 
provide reports regarding their current and childhood ADHD symptoms. Demographic characteristics (i.e., age, 
sex, ethnicity, household income) did not vary by recruitment location (all ps >.22). 
 
A multistage process was used to identify cases and noncases among those who volunteered (see Figure 1). 
Interested participants first completed an eligibility screening process conducted by bachelor’s and master’s 
level research project staff at Stage 1 to evaluate inclusion and exclusion criteria. Participants were excluded if 
they (a) were not fluent in English; (b) had any physical illness or neurological conditions, including a history of 
head injuries, which might compromise central nervous system and cognitive functioning; (c) had a history of 
major psychiatric disorder other than depression or anxiety disorders; (d) had ever been diagnosed with a 
learning disability, (5) had a history of preterm birth (birth prior to 33 weeks gestation); or (e) had significant 
alcohol, illicit drug, or prescription drug abuse (based on the frequency, number of years of use, and total 
amount used per week), that were considered capable of causing impaired cognitive testing performance. While 
prior work has been somewhat inconsistent in including/excluding individuals with comorbid 
neurodevelopmental problems, including learning disorders, we elected to take a conservative approach and 
exclude those with other neurodevelopmental conditions to ensure that any cognitive deficits we observed 
were due to ADHD and not a combination of different problems. Additionally, participants were excluded if they 
were taking long-acting stimulant medications (n = 77) or were not willing to complete a wash out of stimulant 
medication prior to testing (n = 12). A total of 882 participants completed the initial screening process, of which 
282 were excluded. 
 
 
 
Figure 1. Multistage recruitment procedure. 
 
Following the initial screening process, the remaining 600 eligible participants completed the Stage 2 screening 
to determine diagnostic grouping. To be considered for the ADHD group, participants had to endorse having a 
prior diagnosis based upon a comprehensive clinical interview and standardized assessment of psychiatric status 
(i.e., behavioral rating scales) as well as onset of symptoms and impairment prior to Age 16. Any prior diagnosis 
had to have been made during the preceding 4 years. Participants had to meet full DSM–5 diagnostic criteria to 
be retained in the ADHD group. To determine final inclusion in the ADHD group, potential ADHD participants 
completed a semistructured interview of adult ADHD symptoms based on Kessler et al. (2010) to ensure that 
current and childhood symptoms were above DSM–IV/DSM–5 diagnostic thresholds. These thresholds include 
6+ symptoms present during childhood prior to Age 12 and 5+ symptoms present within the past 6 months. A 
total of 307 potential ADHD participants completed the Stage 2 screening, and 109 were deemed eligible and 
enrolled in the study. 
 
To be included in the depressed group, participants had to endorse receiving a diagnosis of a unipolar mood 
disorder from a mental health professional based upon a comprehensive clinical interview and standardized 
assessment of psychiatric status. Additionally, participants had to endorse having at least one mood episode 
during the past year that required either medication or behavioral treatment. We set these criteria in order to 
try to closely compare cognitive performance of individuals with ADHD and those with recent, active symptoms 
of depression. A total of 182 potential depressed group participants completed the Stage 2 screening, and 52 
were deemed eligible and enrolled in the study. 
 
Lastly, (out of the 111 screened) 85 community volunteers presenting with no history of either ADHD or unipolar 
mood disorder were enrolled in the study as controls. While a formal matching process was not implemented, 
control participants were enrolled to approximately correspond to the clinical groups based on age and sex. 
Screening procedures resulted in a total sample of 246 participants (109 ADHD, 52 depressed, and 85 controls). 
All participants completed a standardized neuropsychological testing battery and questionnaire measures, as 
follows. Additionally, all participants were compensated for their time and parking expenses were paid. All 
procedures were approved by the local institutional boards. 
 
Testing Procedures 
Each participant completed a comprehensive neuropsychological evaluation, consistent with recommendations 
for a multimethod assessment of adult ADHD (Frazier, Demaree, & Youngstrom, 2004; Weyandt et al., 2013). 
The testing procedures included multiple cognitive tests, behavioral observations, self and informant ADHD 
behavior rating scales, ratings of depression and anxiety symptoms, PVTs, and an SVT. All participants taking 
stimulant medication completed a 24- or 48-hr wash-out procedure, depending on whether the medicine was 
short or long acting (M wash-out time = 37.4 hr, SD = 14.6). The cognitive tests were administered according to 
standardized instructions by trained and supervised clinical psychology doctoral students and advanced 
undergraduate students. The tests were administered in the same order for all participants (Marshall et al., 
2016). Tests were selected based on review of three meta-analyses of neuropsychological performance among 
adults with ADHD (Alderson, Kasper, Hudec, & Patros, 2013; Boonstra, Oosterlaan, Sergeant, & Buitelaar, 2005; 
Hervey, Epstein, & Curry, 2004) and were included to cover several broad domains, including executive 
functioning (e.g., working memory, inhibition, set-shifting, interference control, planning), memory, processing 
speed, and sustained attention/vigilance. Included tests had a conceptual and empirical association with ADHD 
and the battery was selected to adequately cover verbal, visual, and motor processing domains. 
 
Participants completed the Vocabulary, Block Design, Digit Span, and Symbol Search subtests of the Wechsler 
Adult Intelligence Scale (4th ed.; Wechsler, 2008a); the California Verbal Learning Test-II (CLVT-II; Delis, Kramer, 
Kaplan, & Ober, 2000); the Verbal Fluency, Design Fluency, Color-Word Interference Test (CWIT), and Tower test 
from the Delis-Kaplan Executive Function System (DKEFS; Delis, Kaplan, & Kramer, 2001); the 
Neuropsychological Assessment Battery (NAB) Numbers and Letters Test (White & Stern, 2003); the Word 
Memory Test (WMT; Green, 2003); the Paced Auditory Serial Addition Test (PASAT-100; Diehr et al., 2003); the 
Salthouse Listening Span Test (Salthouse, 1994); the Test of Variables of Attention (TOVA; Greenberg, Kindschi, 
Dupuy, & Corman, 1996); the Dot Counting Test (Boone, Lu, & Herzberg, 2002b); the Sentence Repetition Test 
(Strauss, Sherman, & Spreen, 2006); the Spatial Addition subtest of the Wechsler Memory Scales (4th ed.; 
Wechsler, 2008b), and the b-Test (Boone, Lu, & Herzberg, 2002a). PVT measures were interspersed throughout 
the testing battery, given that effort can fluctuate significantly throughout a testing session (Boone, 2009). The 
following PVT cutoff scores were used to identify suspect effort per Marshall et al. (2016): a score of 6 or less on 
the Reliable Digit Span score (Babikian, Boone, Lu, & Arnold, 2006), two or more errors on the Forced Choice 
Recognition Test of the CVLT-II (Root, Robbins, Chang, & Van Gorp, 2006), a Sentence Repetition score of 10 or 
less (Schroeder & Marshall, 2010), and less than 82.5% correct for the immediate recognition, delay recognition, 
or recall consistency scores on the WMT (Green, 2003). Further, an e-score of 14 or greater on the Dot Counting 
Test, e score of 70 or more on the b-Test, and response variability values of greater than 180 ms, 26 or more 
omission errors, and 31 or more commission errors on the TOVA were used to identify suspect effort. 
 
Following the completion of the testing battery, participants completed several normed behavior rating scales to 
assess ADHD, depression, and anxiety symptomatology. Both participants and their informants completed the 
current and childhood symptom versions of the Barkley Adult ADHD Rating Scale (BAARS-IV, Barkley, 2011a), the 
Barkley Deficits in Executive Function Scale—Short Form (BDEFS-SF; Barkley, 2011b), and the Barkley Functional 
Impairment Scale (BFIS, Barkley, 2011c). The BAARS-IV requires respondents to rate the frequency of all 18 
DSM–IV ADHD symptoms on a 4-point Likert scale (never/rarely, sometimes, often, and very often). Additionally, 
both participants and their informants completed the BDEFS-SF (Barkley, 2011b). The BDEFS requires 
respondents to report the frequency of various executive function-related problems on a 4-point Likert scale 
(never/rarely, sometimes, often, and very often), including difficulties with time management, organization, 
restraint, motivation, and emotion regulation. Participants and their informants also completed the BFIS 
(Barkley, 2011c). The BFIS requires respondents to report the degree to which they believe their ADHD 
symptoms are impairing their functioning across multiple domains (e.g., in completing tasks at home, in their 
interpersonal relationships, in their work/school activities). Lastly, participants also completed the Beck 
Depression Inventory-II (Beck, Steer, & Brown, 1996), a 21-item scale examining the severity of depression 
symptoms as well as the 21-item Beck Anxiety Inventory (Beck & Steer, 1993), which quantifies the severity of 
anxiety symptoms. Finally, both participants and informants also completed the Clinical Assessment of Attention 
Deficit–Adult Infrequency scale (Bracken & Boatwright, 2005) which is an SVT. The endorsement of three or 
more of the 10 items on this scale was considered to be indicative of symptom exaggeration or embellishment 
(Marshall et al., 2016). 
 
Data Analytic Strategy 
Descriptive statistics for the diagnostic measures were first calculated by group (ADHD, depressed, and control) 
and differences evaluated via analysis of variance. To facilitate interpretation of results, all neuropsychological 
test scores were transformed to reduce skewness and mean centered, such that higher scores reflected worse 
performance. Normed values were used for each measure to manage differences related to age and sex. 
Participants who were below thresholds on two or more PVT/SVTs were determined to have made an invalid 
symptom presentation (n = 6, all in the ADHD group), based on prior work (Marshall et al., 2016). 
 
Prior to conducting the primary analyses, the diagnostic accuracy of each neuropsychological test measure was 
preliminarily assessed via calculation of the area under the curve (AUC) via a series of receiver operator 
characteristic (ROC) analyses. These analyses examined the utility of each measure in distinguishing each dyadic 
grouping (i.e., ADHD vs. non-ADHD, ADHD vs. control, and ADHD vs. depressed). Measures with AUC values 
significantly greater than .50 (which represents the probability that a test score will rank a randomly chosen case 
higher than a randomly chosen noncase) were retained for the primary analyses. 
 
Regression analyses were then conducted to evaluate our primary questions regarding the utility of 
neuropsychological test measures for distinguishing adult ADHD. Specifically, a series of stepwise binary logistic 
regression analyses as well as a multinomial logistic regression were conducted to determine which measures 
best distinguished participants with ADHD from those without ADHD (including controls and patients with 
depression). In these models, all neuropsychological test measures were included as predictors and an iterative 
process was used to determine the best fitting model. Standardized, mean-centered scores were used as the 
predictors (all skewness <.70) and estimated full-scale IQ and stimulant medication status were included as 
covariates. Outcomes included binary diagnostic groupings (i.e., ADHD vs. non-ADHD, ADHD vs. control, ADHD 
vs. depressed) and the three-group multinomial comparison (i.e., ADHD vs. control vs. depressed). Model fit was 
evaluated using the omnibus chi-square as well as the Hosmer and Lemeshow chi-square statistics. In addition 
to models predicting diagnostic group, additional analyses also examined test measures as predictors of 
dimensional scores of ADHD symptom severity and impairment (mean of self- and informant ratings) using a 
stepwise linear regression framework. Neuropsychological test measures that were found to significantly and 
incrementally contribute to the prediction of group membership and/or the variance in symptom severity were 
then retained for a subset of further analyses. 
 
Next, we utilized a series of procedures to determine the best method for combining rating scale and test data 
for predicting diagnostic grouping. First, specific cut scores that optimized sensitivity, specificity, positive 
predictive power, and negative predictive power were determined for a final subset of neuropsychological test 
measures based on the prior analyses. We retained measures that were found to: (a) have marginal or better 
(>.60) AUC values, and (b) significantly and incrementally contribute to the prediction of diagnostic group and/or 
symptom severity variance. From here, we utilized a series of stepwise binary logistic regression analyses to 
determine the degree to which each of the following indicators improved prediction of ADHD diagnoses: (a) self-
reports of current symptoms and impairment, (b) self-report of childhood symptoms, (c) informant reports of 
current symptoms, (d) family history of ADHD diagnosis, and (e) our subset of best-performing 
neuropsychological test cut scores. 
Results 
Descriptive Statistics 
Demographic and descriptive statistics for the sample are presented in Table 1. As seen there, our recruitment 
and diagnostic assessment procedures were effective in distinguishing our groups. As expected, adults in the 
ADHD group had significantly higher levels of inattention and hyperactivity-impulsivity symptoms, both currently 
and during childhood. They were significantly more likely to be taking stimulant medication than those in the 
depressed or nondisordered control groups. Notably, adults in the depressed group had significantly higher 
scores on the BDI than the ADHD and control groups. While adults in the depressed group reported higher levels 
of ADHD symptoms compared with controls, these did not reach clinical diagnostic thresholds. As expected, 
there was a higher proportion of males in the ADHD group relative to the depressed and control groups. 
Importantly, however, the three groups did not differ in regard to age, ethnicity, and years of education. 
Notably, average IQ and education were generally above average relative to population norms. 
 
Table 1. Demographic and Descriptive Statistics for ADHD and Non-ADHD Control and Depressed Participants 
 
Sample characteristic Control ADHD Depressed p value Diff 
N 85 109 52   
Male (%) 32.9 49.5 28.8 .01 A, C > D 
Caucasian (%) 80.0 85.3 86.5 .29  
Age 22.9 (4.5) 24.8 (6.2) 23.6 (5.4) .06  
Education (years) 14.9 (1.9) 15.4 (2.5) 15.0 (2.2) .24  
Stimulant medication (%) 0 76.1 0 <.001 A > D, C 
Current inattention symptoms .62 (1.4) 5.1 (2.8) 2.4 (2.8) <.001 A > D > C 
Current hyperactive-impulsive symptoms .95 (1.5) 3.9 (2.4) 1.9 (2.3) <.001 A > D > C 
Childhood inattention symptoms 1.0 (2.0) 5.5 (3.1) 1.8 (2.6) <.001 A > D, C 
Childhood hyperactive-impulsive symptoms 1.3 (1.9) 4.6 (3.1) 1.9 (2.4) <.001 A > D, C 
BDEFS percentile score 56.0 (21.4) 84.7 (15.9) 78.9 (19.4) <.001 A, D > C 
BFIS percentile score 58.6 (12.9) 77.1 (15.0) 74.0 (16.6) <.001 A, D > C 
Informant inattention symptoms .43 (1.1) 4.0 (2.7) 1.9 (2.3) <.001 A > D > C 
Information hyperactive-impulsive symptoms .58 (1.4) 3.3 (2.7) 1.2 (1.8) <.001 A > D, C 
Beck Depression Inventory score 5.0 (5.1) 10.5 (8.2) 16.0 (10.9) <.001 D > A > C 
Beck Anxiety Inventory score 2.8 (5.1) 8.5 (8.8) 9.4 (9.1) <.001 D, A > C 
Note. p value indicates significant difference at level of three groups. Stimulant medication indicates proportion 
of participants taking stimulant medication at time of assessment (and how underwent washout procedure). 
Values in parentheses are standard deviations. Diff _ pattern of post hoc group differences; BDEFS _ Barkley 
Deficits in Executive Function Scale; BFIS = Barkley Functional Impairment Scale; A = attention-
deficit/hyperactivity disorder (ADHD); D = depressed, C = control. 
 
Neuropsychological Test Measures 
ROC analyses indicated that several test measures were marginal or better predictors of diagnostic group 
membership (Table 2). These analyses were first conducted examining measures distinguishing ADHD versus all 
non-ADHD participants (depressed and control patients both) followed by analyses distinguishing ADHD versus 
control and ADHD versus depressed group membership. Notably these analyses produced completely 
overlapping results and identified several test measures for inclusion in subsequent regression analyses. These 
measures included: CVLT short delay free recall, all three indices from the Salthouse Listening Span Test, DKEFS 
Letter Fluency, DKEFS CWIT inhibition/switching, DKEFS Design Fluency test filled and empty dots, and the 
reaction time (RT) variability, RT, omission errors, and d-prime score from the TOVA, and the speed score from 
the NAB Numbers and Letters test. 
 
Table 2. Receiver Operating Characteristic Analyses for Neurocognitive Test Measures: ADHD Versus Non-ADHD 
 
Neurocognitive measures AUC p value 95% CI 
CVLT Trial 1 .51 .91 [.43, .58] 
CVLT Trial 5 .55 .17 [.48, .63] 
CVLT short delay free recall .59 .01 [.52, .66]a,b 
CVLT long delay free recall .56 .12 [.48, .64] 
CVLT recognition .51 .81 [.43, .58] 
Listening Span trials .63 <.001 [.56, .70]a,b 
Listening Span items .61 .003 [.54, .68]a,b 
Listening Span score .62 .001 [.55, .69]a 
Sentence repetition .55 .18 [.48, .62] 
WMS Spatial Addition .53 .37 [.46, .61] 
Letter fluency .58 .03 [.51, .65]a 
Color naming .52 .53 [.45, .60] 
Word reading .55 .22 [.47, .62] 
Inhibition .53 .44 [.46, .60] 
Inhibition/switching .60 .009 [.53, .67]a,b 
Design Fluency filled .59 .02 [.51, .66]a 
Design Fluency empty .58 .03 [.51, .66]a 
Design Fluency switching .55 .16 [.48, .63] 
Tower .56 .12 [.49, .63] 
PASAT .49 .73. [41, .55] 
TOVA reaction time variability .66 <.001 [.59, .74]a,b 
TOVA reaction time .65 <.001 [.58, .72]a,b 
TOVA commission errors .56 .15 [.48, .63] 
TOVA omission errors .66 <.001 [.59, .73]a,b 
TOVA d-prime .64 <.001 [.57, .72]a,b 
Numbers and letters speed .59 .04 [.51, .67]a 
Numbers and letters efficiency .43 .07 [.36, .50] 
Note. Bolded measures had AUC scores significantly greater than .50. ADHD = attention-deficit/hyperactivity 
disorder; AUC = area under the curve; CVLT = California Verbal Learning Test; WMS = Wechsler Memory Scales; 
PASAT = Paced Auditory Serial Addition Test; TOVA = Test of Variables of Attention.  
a
 Scores indicate significant AUC in analyses examining ADHD versus controls.  
b
 Scores with indicate significant AUC in analyses examining ADHD versus depressed. 
 
Predicting Diagnostic Group Membership 
ADHD versus non-ADHD 
Stepwise binary logistic regression analyses were first used to examine these test measures as predictors of 
group status (ADHD vs. non-ADHD, including both individuals in the depressed and the control groups; Table 3). 
Findings indicated that the best-fitting model included five significant test measures as predictors of ADHD 
diagnostic status and improved model fit compared with the intercept-only model (omnibus χ2 = 44.7, p < .001; 
Hosmer and Lemeshow χ2 = 11.2, p = .19; Nagelkerke R2 = .23). Examination of parameters indicated that worse 
performance (indexed by higher scores) on CVLT short-delay free recall (β = .33, p = .029, odds ratio (OR) = 1.4, 
95% CI [1.03, 1.9]), Salthouse Listening Span trials (β = .35, p = .021, OR = 1.4, 95% CI [1.1, 1.9]), DKEFS CWIT 
inhibition/switching (β = .37, p = .012, OR = 1.5, 95% CI [1.1, 1.9]), TOVA RT variability (β = .36, p = .030, OR = 1.4, 
95% CI [1.0, 2.0]), and TOVA omission errors (β = .43, p = .01, OR = 1.5, 95% [CI 1.1, 2.1]) all significantly and 
incrementally predicted membership in the ADHD group compared with the non-ADHD group, with an overall 
classification accuracy of 72.1%. 
 
Table 3. Neurocognitive Test Measures as Predictors of ADHD Diagnostic Groupings: Stepwise Logistic 
Regression Analyses 
 
Measure  β p value OR  CI 
ADHD vs. non-ADHD     
CVLT short delay .33 .029 1.4 [1.03, 1.9] 
Listening span .35 .021 1.4 [1.1, 1.9] 
CW inhibition/switching .37 .012 1.5 [1.1, 1.9] 
TOVA reaction time variability .36 .030 1.4 [1.1, 2.0] 
TOVA omission errors .43 .010 1.5 [1.1, 2.1] 
ADHD vs. control     
Listening Span .45 .008 1.6 [1.1, 2.2] 
TOVA omission errors .73 <.001 2.1 [1.5, 3.0] 
ADHD vs. depressed     
CVLT short delay .37 .039 1.4 [1.0, 2.1] 
TOVA reaction time .48 .008 1.6 [1.1, 2.3] 
Three-group multinomial     
Listening Span .46 .006 1.6 [1.1, 2.2] 
TOVA omission errors .72 <.001 2.1 [1.5, 3.0] 
Note. β = betas from logistic regression analyses; ADHD _ attention-deficit/hyperactivity disorder; OR _ odds 
ratio; CI _ 95% confidence interval for odds ratio; CVLT  California Verbal Learning Test; CW = Color-Word; TOVA 
_ Test of Variables of Attention. 
 
ADHD versus control 
A second stepwise binary logistic regression analyses was conducted to determine which neuropsychological 
test measures best distinguished participants with ADHD from nondisordered controls. Here, findings indicated 
that the best-fitting model included two predictors and improved model fit relative to the intercept-only model 
(omnibus χ2 = 30.1, p < .001; Hosmer and Lemeshow χ2 = 6.4, p = .61; Nagelkerke R2 = .20). In this model, worse 
performance on both Salthouse Listening Span trials (β = .45, p = .008, OR = 1.6, 95% CI [1.1, 2.2]) and TOVA 
omission errors (β = .73, p < .001, OR = 2.1, 95% CI [1.5, 3.0]) significantly predicted membership in the ADHD 
group compared with nondisordered controls, with a classification accuracy of 68.3%. 
 
ADHD versus depressed 
A third stepwise binary logistic regression analysis was used to determine which test measures best 
distinguished ADHD participants from those with the depression. Again, two test measures emerged as 
predictors in the best-fitting model, which exhibited improved fit relative to the intercept-only model (omnibus 
χ2 = 12.8, p = .002; Hosmer and Lemeshow χ2 = 7.7, p = .47; Nagelkerke R2 = .11). Worse performance on the 
CVLT short-delay free recall (β = .37, p = .039, OR = 1.4, 95% CI [1.0, 2.1]) and TOVA RT (β = .48, p = .008, OR = 
1.6, 95% CI [1.1, 2.3]) were associated with membership in the ADHD group relative to the depressed group, 
with a classification accuracy of 70.4%. 
 
Multinomial logistic regression 
Similarly, a stepwise multinomial logistic regression analysis was conducted to determine which 
neuropsychological test measures distinguished best among all three groups. The iterative procedure again 
revealed two measures best distinguished the three groups and improved model fit relative the intercept-only 
model (omnibus χ2 = 34.3, p < .001; Hosmer and Lemeshow χ2 = 16.3, p = .46; Nagelkerke R2 = .15). Again, worse 
performance on both the Salthouse Listening Span trials (β = .46, p = .006, OR = 1.6, 95% CI [1.1, 2.2]) and TOVA 
omission errors (β = .72, p < .001, OR = 2.1, 95% CI [1.5, 3.0]) significantly predicted membership in the ADHD 
group compared with nondisordered controls. However, neither measure distinguished depressed patients from 
controls (all ps > .26). 
 
Predicting Symptom Severity and Impairment 
Stepwise linear regression analyses were then conducted to determine which test measures best predicted 
dimensional scores of inattention, hyperactivity-impulsivity, and functional impairment (Table 4). All models 
included current stimulant medication usage and estimated full-scale IQ as covariates. Two measures (TOVA RT 
variability, DKEFS CWIT inhibition/switching) each contributed incrementally to predicting inattention and 
together combined to predict 8% of the variance in these symptom severity scores. By contrast, TOVA omission 
errors and Salthouse Listening Span trials each uniquely predicted hyperactivity—impulsivity and accounted for 
6% of the variance. TOVA RT variability and CVLT short delay free recall each predicted scores on the BDEFS-SF 
and together accounted for 8% of the variance. TOVA RT and Salthouse Listening Span trials both predicted 
functional impairment due to ADHD symptoms as reported on the BFIS and accounted for 6% of the variance. 
Thus, it appears that variability in neurocognitive functioning, specifically, in sustained attention and working 
memory functioning accounted for unique variation in severity of symptoms and impairment. 
 
Table 4. Neurocognitive Test Measures as Predictors of Ratings of ADHD Symptom Severity, Executive Function 
Deficits, and Functional Impairments: Stepwise Linear Regression Analyses 
 
Predictor b Β p 
value 
95% CI R2 (Δ R2) 
Current inattention sum score (mean self and informant)      
TOVA reaction time variability  .23 .23 <.001 [.21, 
.34] 
 
CW inhibition/switching .16 .16 <.001 [.06, 
.26] 
.35 
(.08) 
Current hyperactivity-impulsivity sum score (mean self and 
informant) 
     
TOCA omission errors .22 .22 <.001 [.11, 
.33] 
 
Listening Span trials .12 .13 .034 [.01, 
.23] 
.21 
(.06) 
BDEFS percentile      
TOVA reaction time variability  .27 .27 <.001 [.10, 
.44] 
 
CVLT short delay free recall .13 .13 .03 [.05, 
.21] 
.20 
(.08) 
BFIS percentile      
TOVA reaction time .17 .17 .01 [.04, 
.30] 
 
Listening Span trials .17 .17 .006 [.05, 
.29] 
.15 
(.06) 
Note. Total R2 value is for full model including covariates of IQ and stimulant medication. Change in R2 (ΔR2) 
represents the incremental variance explained by the neurocognitive measures. ADHD = attention-
deficit/hyperactivity disorder; TOVA = Test of Variables of Attention; CW = Color-Word; CVLT = California Verbal 
Learning Test; BDEFS = Barkley Deficits in Executive Function Scale; BFIS = Barkley Functional Impairment Scale. 
 
Determining Cut Scores and Individual Test Diagnostic 
Individual neuropsychological test measures 
Overall, six test measures consistently emerged when predicting diagnostic group membership as well as 
symptom severity and ADHD-related impairments: CVLT short delay free recall, Salthouse Listening Span trials, 
DKEFS CWIT inhibition/switching condition, and the RT variability, RT, and omission errors indices from the 
TOVA. We utilized the ROC data to calculate cut scores for each measure that maximized sensitivity and 
specificity for each in predicting ADHD group membership. We calculated Youden’s J statistics for each potential 
cut-score (defined as sensitivity + specificity − 1), which specify the score that can maximize both sensitivity and 
specificity for each measure. Results are presented in Table 5. Overall, the cut scores identified as most optimal 
for distinguishing ADHD and non-ADHD participants were generally within the average range compared with the 
established norms for each test measure, which is consistent with the above average levels of education and 
above average IQ of the sample. 
 
Table 5. Optimizing Sensitivity and Specificity for Key Neurocognitive Test Predictors of ADHD Diagnosis and 
Symptom Severity 
Test measure and cut-score Sensitivity Specificity cPPP cNPP Youden 
CVLT short delay free recall      
<-.75 .22 .97 3.0 .80 .19 
<-.25 .43 .77 1.69 .76 .20 
<.25 .54 .59 1.32 .78 .13 
<.75 .67 .40 1.13 .81 .07 
Salthouse Listening Span trials      
<7 .25 .88 .73 .48 .13 
<8 .40 .81 .73 .51 .21 
<9 .59 .66 .69 .55 .25 
<10 .74 .46 .63 .58 .20 
DKEFS inhibition/switching      
<8 .13 .95 .78 .46 .08 
< 9 .23 .88 .71 .47 .11 
<10 .41 .68 .63 .48 .09 
<11 .55 .54 .61 .48 .09 
TOVA reaction time      
variability      
<80 .37 .91 .83 .53 .28 
<85 .47 .85 .80 .55 .32 
<95 .51 .82 .79 .60 .33 
<100 .66 .68 .73 .61 .34 
<105 .75 .46 .64 .59 .21 
TOVA reaction time      
<100 .32 .84 .71 .49 .16 
<105 .40 .79 .71 .51 .19 
<110 .55 .70 .69 .54 .25 
<115 .64 .60 .67 .57 .24 
<120 .72 .47 .64 .57 .19 
TOVA omission errors      
<90 .39 .89 .82 .53 .28 
<95 .50 .85 .81 .57 .35 
<100 .58 .75 .75 .58 .33 
<105 .72 .51 .65 .58 .26 
Note. Bolded values indicate optimal cut score for each measure based on Youden statistics. Corrected positive 
and negative predictive power used estimated base rate of 30 percent. Scores for California Verbal Learning Test 
(CVLT) Short Delay Free Recall are z scores. Scores from Salthouse Listening Span Trials are raw scores. Scores 
from Delis-Kaplan Executive Function System (DKEFS) Inhibition/Switching are scaled scores. Scores from Test of 
Variables of Attention (TOVA) measures are standard scores. cPPP = corrected positive predictive power; cNPP = 
corrected negative predictive power. 
 
Combining rating scale and neuropsychological test measures 
We next evaluated the utility of using these cut scores in combination with rating scale information. A stepwise 
binary logistic regression was used to examine self-reports of current symptoms and impairment, informant 
reports of current symptoms and impairment, family history of ADHD, and neuropsychological test measure cut 
scores as predictors of ADHD diagnostic status. Each step of the model retained significant unique predictors 
and eliminated nonsignificant predictors (Table 6). Results indicated that self-reports of ADHD and depression 
symptoms significantly distinguished ADHD from non-ADHD participants. Addition of retrospective childhood 
reports as well as informant reports to the model at Steps 2 and 3 also significantly improved classification 
accuracy. Notably, reports of family history of ADHD diagnosis in first-degree family members also significantly 
improved classification accuracy, particularly for ADHD participants. Of our six neuropsychological test 
measures, only TOVA RT variability added incrementally to predicting group membership. However, the OR was 
relatively larger (OR = 3.1) and classification accuracy improved to 87.2% (from 85.4%), suggesting that addition 
of this one neuropsychological test did improve diagnostic classification within this sample. 
 
Table 6. Diagnostic Accuracy of Combined Approach: Self-Ratings of Current Symptoms, Childhood Symptoms, 
Informant Ratings, Family History, and Neurocognitive Test Cut Scores in Predicting ADHD and Non-ADHD Group 
Status 
 
Included information β p OR (CI) Classification accuracy (non-ADHD, 
ADHD) 
Step 1: self-report current behavior     
Current ADHD symptom score .16 <.001 1.2 [1.1, 1.3]  
Current BDI score -.06 .008 .94 [.90, .98] 77.4 (76.4, 78.6) 
Step 2: self-report childhood 
behavior 
    
Childhood inattention symptoms .12 .009 1.12 [1.03, 
1.21] 
80.9 (80.3, 81.6) 
Step 3: informant report current 
behavior 
    
Informant ADHD symptom score .19  <.001,  1.21 [1.15, 
1.27]  
82.6 (81.9, 83.5) 
Step 4: family history of ADHD     
First degree family member with 
ADHD 
1.24 .033 3.5 [1.5, 7.8] 85.2 (81.9, 89.3) 
Step 5: neurocognitive test cut 
scores 
    
TOVA reaction time variability 1.14 .023 3.1 [1.1, 8.9] 87.4 (86.6, 88.3) 
Note. ADHD _ attention-deficit/hyperactivity disorder; BDI = Beck Depression Inventory; TOVA = Test of 
Variables of Attention. 
Discussion 
The current study examined multiple neuropsychological test measures in conjunction with self- and informant 
ratings of current and childhood ADHD symptoms in order to ascertain the extent to which inclusion of these 
behavioral measures might improve the diagnostic accuracy of adult ADHD assessment. The current work sought 
to extend past research in this area by examining a large battery of neuropsychological test measures as well as 
several PVTs and SVTs, among a diverse sample of adults with ADHD as well as nondisordered controls and 
adults with depression. 
 
There are four sets of notable findings stemming from this work. First, our analyses found that a combined 
approach that utilized self and informant ADHD symptom ratings, family history of ADHD, and 
neuropsychological test measures yielded a classification accuracy of approximately 87% when distinguishing 
participants with and without ADHD. Similar to past work, our findings support including retrospective ratings of 
childhood symptoms, particularly inattention (Kooij et al., 2010), along with informant ratings of behavior in the 
diagnostic assessment of ADHD (Sibley et al., 2017). Additionally, inclusion of ADHD family history, which is 
sometimes (although not always) gathered as part of an unstructured interview, significantly increased the 
classification accuracy. This suggests that it may be advantageous to gather this information in research and 
clinical assessment of ADHD, even if that information is not formally part of the diagnostic criteria. 
 
Second, our findings regarding the role of neuropsychological test measures in the diagnostic assessment of 
ADHD were mixed. ROC analyses as well as linear and logistic regression analyses identified a subset of 
measures that each uniquely added to the discrimination between ADHD and non-ADHD adults. These measures 
included indices of working memory, inhibition, response speed and variability, and sustained attention, all 
domains which largely correspond to the largest group-difference effect sizes in the ADHD neurocognitive 
literature (Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). Notably, three of these six measures were from 
the TOVA, suggesting that indices of response speed, response variability, and sustained attention may be 
particularly important for identifying adult ADHD. However, the TOVA may have also emerged as a salient 
predictor of diagnostic group due to its superior measurement precision (e.g., RTs and accuracy of performance 
are measured via computer and calculated in milliseconds), which may increase the sensitivity of this test for 
identifying deficits in sustained attention. 
 
Furthermore, similar to much of the past work in this area, each single neuropsychological test measure poorly 
discriminated individuals with and without ADHD, based on the ROC analyses. In fact, several measures 
commonly used in clinical practice (i.e., the PASAT, NAB Numbers and Letters) were no better than chance at 
distinguishing individuals with and without ADHD (i.e., controls and depressed participants) Thus, inclusion of a 
long and extensive neuropsychological testing battery does not appear to yield much in terms of improving the 
diagnostic accuracy of adult ADHD assessment. 
 
Third, additional analyses of these neuropsychological test measures that aimed to maximize the sensitivity and 
specificity of their prediction of ADHD diagnostic status revealed cut scores that were largely in the average 
range relative to the norms developed for each measure. This may be due, in part, to the overall higher levels of 
educational attainment and intellectual functioning in this sample. Some prior work has suggested that higher 
intellectual functioning may potentially “mask” executive functioning deficits in particular among adults with 
ADHD (Milioni et al., 2017). Further, these findings are in line with past work, which has suggested that adults 
with ADHD may exhibit less severe neuropsychological impairment (Salomone, Fleming, Bramham, O’Connell, & 
Robertson, 2016), but may instead show more heterogeneity in terms of degree and types of cognitive deficits 
(Mostert et al., 2018). Regardless, this set of findings may be particularly relevant in the assessment of ADHD 
among college students. That is, adults with above average global cognitive abilities may underperform on some 
of these tasks relative to their IQ, even though their performance may be within an average range when 
compared with a broader population of adults. (Weyandt et al., 2013). 
 
Further, our findings of average-range cut scores that discriminated ADHD and non-ADHD participants within 
our sample may also explain findings from prior work regarding the lack of utility of neuropsychological tests in 
diagnosing adult ADHD. That is, neuropsychological tests may not have appeared to be useful for diagnosis in 
some prior work if an individual had to score substantially below the included norms (rather than low relative to 
a comparison or peer group) to be deemed impaired on a particular measure. While this may not account for all 
of the mixed findings in past research regarding the utility of neuropsychological tests in diagnosing adult ADHD, 
our findings strongly suggest that the criteria used to identify impairment on any neuropsychological tests be 
considered carefully and in relation to the individual’s appropriate reference group (e.g., college-educated 
adults, high-average intellectual functioning). Future work may benefit by developing college-level norms for 
some measures commonly used in neuropsychological research and in evaluations of young adults with ADHD 
(Weyandt et al., 2013). 
 
Fourth, our findings did not reveal many problems with invalid symptom presentation based on the results of 
PVTs and a symptom validity measure. Only 2% of the participants in this study were identified as making an 
invalid symptom presentation (i.e., below thresholds on 2 or more PVTs/SVTs). This is a substantially lower 
percentage than those found in studies of young adult patients presenting for ADHD assessment in clinical 
settings. Based on the conservative Slick, Sherman, and Iverson (1999) malingering criteria, prior work has 
estimated that 27% (Marshall et al., 2016), 22% (Marshall, et al., 2010), and 10% (Pella, Hill, Shelton, Elliott, & 
Gouvier, 2012) of college students made a suspect effort in their cognitive assessments. However, the 
participants in the current study had already been diagnosed with ADHD and their retaining this diagnosis was 
not in question. Therefore, it is highly likely that the participants in our study did not have the same set of 
incentives or motivations for making an invalid symptom presentation. Unfortunately, this unusually small 
percentage of individuals making an invalid symptom presentation prevented this study from producing 
meaningful data concerning the incremental predictive validity of including validity measures in an ADHD 
assessment battery. Nevertheless, prior work and clinical practice guidelines have strongly supported the need 
for such PVTs in order to identify invalid symptom presentation in this group, which may obscure clinical 
assessment and diagnosis of adults with ADHD (Bush et al., 2005; Heilbronner et al., 2009; Marshall et al., 2016; 
Tucha, Fuermaier, Koerts, Groen, & Thome, 2015). 
 
Overall, our findings supported including the following measures in a diagnostic assessment of ADHD (in 
addition to the clinical interview): (a) self-reports of ADHD, functional impairment, and potential comorbid 
problems, including depression; (b) retrospective reports of childhood ADHD symptoms; (c) informant reports of 
symptoms; (d) any positive family history of ADHD diagnoses; (e) performance and symptom validity measures; 
and (f) the TOVA or similar computerized continuous performance task. While our findings only offer some 
support for inclusion of neuropsychological tests in the diagnostic assessment of adult ADHD, more work is 
needed to determine if such tests significantly benefit diagnostic decision making in situations in which the 
results of other means of assessment (i.e., rating scales, clinical interview) are equivocal. Additionally, while 
these neuropsychological measures may slightly increase diagnostic accuracy, assessments of neurocognitive 
functioning, via testing or behavior ratings (e.g., the BDEFS), may be beneficial for understanding impairment 
and treatment targets in studies of intervention (Kooij et al., 2010; Solanto et al., 2010). Further, recent work 
focusing on neuropsychological test performance among adults with ADHD has demonstrated significant 
heterogeneity in performance across individuals (van Lieshout et al., 2013), some of which does not appear to 
be connected to the persistence or remittance of ADHD symptoms. Indeed, recent controversial work has even 
suggested that adult-onset ADHD may be a separate syndrome and associated with disparate risk factors and 
outcomes (Moffitt et al., 2015), although this possibility has also been questioned (Agnew-Blais et al., 2016). 
 
There are several limitations to the current work. First, while our battery was comprehensive, some potentially 
ADHD-related behavioral problem domains may not have been properly covered in our measures. Measures of 
reward responsivity (von Rhein et al., 2015; Wetterling et al., 2015), emotional dysregulation (Barkley, 2015), 
and temporal discounting (Jackson & MacKillop, 2016), in particular, may provide additional utility in 
distinguishing adults with and without ADHD. Second, the limited precision of cognitive processing speed 
measurement on some tasks may have limited their utility. Future work may benefit by incorporating 
computerized measures of several of these tasks to determine if improvement in cognitive processing speed 
measurement precision may enhance their usefulness in clinical assessment. For example, computerized 
working memory tests that include speed and accuracy measures might significantly increase the sensitivity of 
these tests to ADHD-related deficits (Alderson et al., 2013). 
 
This work was also limited by considering only one clinical comparison group (e.g., depression). Examination of 
the degree to which these measures may distinguish among those with ADHD and other common comorbidities 
in adulthood, particularly anxiety disorders, as well as the impact of comorbid ADHD and internalizing symptoms 
on multiple domains of cognitive functioning, will be essential to future research in this area. We also excluded 
many individuals with comorbid neurodevelopmental problems (e.g., learning disorders). While there is 
evidence of shared deficits among individuals with ADHD and learning disorders, and enhanced deficits among 
those with comorbid profiles, we elected to exclude individuals with learning disorders in the current study. This 
decision may have then actually contributed to an underestimation of group differences observed, given that 
these excluded individuals with comorbid profiles may have performed equally poor or worse on our test 
battery relative to those with ADHD alone. Additionally, the relative smaller size of the depressed group may 
limit the generalizability of our findings regarding distinctions (or lack thereof) in cognitive performance among 
adults with ADHD and those with depressive disorders. 
 
Future work would also benefit by examining neuropsychological tests and symptom validity measures as 
predictors of ADHD diagnosis in particular cases in which traditional clinical interviews and rating scales have 
produced equivocal findings. That is, some of these measures may not have considerable utility in distinguishing 
those individuals at the extreme end of the symptomatology distributions (i.e., those with severe ADHD 
symptoms, those with no ADHD symptoms). However, they may be more useful in distinguishing among those in 
the middle portion of the symptom severity distribution, particularly given the arbitrary nature of diagnostic cut 
points. That is, the utility of neuropsychological tests in identifying ADHD may indeed vary as a function of 
symptom severity. 
 
Lastly, our sample was limited to volunteer research participants who were predominately Caucasian and who 
had completed a college degree. These three factors (self-selection, ethnic homogeneity, higher education level) 
may limit the generalizability of our findings. It is also important to note that we implemented multiple 
measures of symptom and performance validity into our battery, in line with current concerns regarding adults 
feigning ADHD (see the December 2017 issue of Psychological Assessment including Fuermaier et al., 2017; 
Walls, Wallace, Brothers, & Berry, 2017). However, our ADHD participants had already been diagnosed 
previously, which may be one reason that our validity measures revealed few participants with questionable 
performance. Even so, examination of symptom and performance validity remains of paramount concern in 
assessment of adult ADHD. 
 
Overall, findings from the current study indicated that neuropsychological testing added incrementally in 
predicting ADHD diagnoses among young adults. However, effects were small and the utility of individual tests 
was modest in the absence of other assessment information. A diagnostic protocol that included self- and 
informant ratings of current and childhood symptoms, family history of ADHD, and performance on a continuous 
performance test had high classification accuracy and appeared to be the most efficient in diagnosing ADHD 
among adults. Future work should incorporate performance and validity assessments as well as determine the 
utility of this battery in predicting ADHD diagnosis and related impairments across the spectrum of ADHD 
symptom severity. 
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